Drug
Aln Pcs02
Aln Pcs02: highest development phase Phase 1, developed by Alnylam Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alnylam Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALN-PCS02 NCT01437059 | Phase 1 | Elevated LDL-Cholesterol (LDL-C) |
Latest
No recent events.
Follow Aln Pcs02 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.